Bioventix (FRA:51B) Margin of Safety % (DCF Dividends Based): 58.24% (As of Jul. 12, 2026)


FRA:51B Bioventix PLC FRA:51B
67 GF Score
Price €18.90
GF Value €38.70
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Bioventix Margin of Safety % (DCF Dividends Based)?

Bioventix FRA:51B +8.00% 67 Margin of Safety % (DCF Dividends Based) is 58.24% as of Jul. 12, 2026. GuruFocus rates FRA:51B with a GF Score™ of 67/100 and a GF Value™ of €38.70 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

As of today (2026-07-12), Bioventix's Predictability Rank is 2.5-Stars. Bioventix's intrinsic value calculated from the Discounted Dividend model is €26.82 and current share price is €18.90. Consequently,

Bioventix's Margin of Safety % (DCF Dividends Based) using Discounted Dividend model is 58.24%.

FRA:51B vs VRTX, REGN, ALNY: Margin of Safety % (DCF Dividends Based) Comparison

For the Biotechnology subindustry, Bioventix's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioventix Margin of Safety % (DCF Dividends Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bioventix's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where Bioventix's Margin of Safety % (DCF Dividends Based) falls into.


FRA:51B
67GF Score
Bioventix PLC FRA:51B
Margin of Safety % (DCF Dividends Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioventix Margin of Safety % (DCF Dividends Based) Calculation

Bioventix's Margin of Safety % (DCF Dividends Based) for today is calculated as

Margin of Safety % (DCF Dividends Based)=(Intrinsic Value: DCF (Dividends Based)-Current Price)/Intrinsic Value: DCF (Dividends Based)
=(45.26-18.90)/45.26
=58.24 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted Dividend model with default parameters.

What does a Margin of Safety % (DCF Dividends Based) of 58.24% mean?
Bioventix (FRA:51B) has a Margin of Safety % (DCF Dividends Based) of 58.24% as of Jul. 12, 2026. Margin of Safety % (DCF Dividends Based) is the percent difference between the current price and the intrinsic DCF Dividends price. View historical data on Bioventix.
Is Bioventix's Margin of Safety % (DCF Dividends Based) too high?
Bioventix's current Margin of Safety % (DCF Dividends Based) is 58.24%. Overall, Bioventix has a GF Score™ of 67/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bioventix's Margin of Safety % (DCF Dividends Based) compare to VRTX and REGN?
Bioventix's Margin of Safety % (DCF Dividends Based) of 58.24% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Margin of Safety % (DCF Dividends Based) for a Biotechnology company?
A good Margin of Safety % (DCF Dividends Based) depends on the Biotechnology industry context. However, Margin of Safety % (DCF Dividends Based) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Margin of Safety % (DCF Dividends Based) mean?
A high Margin of Safety % (DCF Dividends Based) can signal that a stock is expensive relative to its fundamentals. Margin of Safety % (DCF Dividends Based) is the percent difference between the current price and the intrinsic DCF Dividends price. View historical data on Bioventix. Bioventix's current Margin of Safety % (DCF Dividends Based) is 58.24%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioventix stock overvalued right now?
Based on GuruFocus' analysis, Bioventix (FRA:51B) is currently considered Significantly Undervalued. The stock's GF Value™ is €38.70, compared to a current price of €18.90 — trading 51.2% below its estimated fair value. The current Margin of Safety % (DCF Dividends Based) is 58.24%. Bioventix's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Margin of Safety % (DCF Dividends Based) calculated?
Margin of Safety % (DCF Dividends Based) is calculated from a company's financial statements. For Bioventix (FRA:51B), the current Margin of Safety % (DCF Dividends Based) is 58.24% as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bioventix (FRA:51B) Overvalued in 2026?

Based on GuruFocus' analysis, Bioventix stock appears to be undervalued. The current stock price of €18.90 is trading 51.2% below its estimated GF Value™ of €38.70. GuruFocus considers Bioventix to be Significantly Undervalued.

Key valuation signals for FRA:51B:

  • Margin of Safety % (DCF Dividends Based): 58.24%
  • GF Value™: €38.70 vs. price of €18.90 (51.2% below fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the FRA:51B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bioventix Business Description

Other Exchanges BVXP:UK
Address 27-28 Eastcastle Street, London, GBR, W1W 8DH
Bioventix PLC is a biotechnology company based in the United Kingdom. It specializes in the creation and supply of high-affinity sheep monoclonal antibodies and clinical diagnostics and drug abuse testing. The company's portfolio of products includes drugs that are applicable in the areas of cardiology, fertility, infectious diseases, Thyroid, and vitamin D disorder among others. It earns maximum revenue from European country.
67GF Score

Get the complete analysis for FRA:51B

Margin of Safety % (DCF Dividends Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€18.90
Price
€38.70
GF Value